» Articles » PMID: 20215420

Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-positive Oropharyngeal Squamous Carcinoma Cells

Overview
Journal Mol Cancer Res
Specialty Cell Biology
Date 2010 Mar 11
PMID 20215420
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

We sought to determine the role of human papillomavirus (HPV) E6 and E7 oncogenes in nuclear beta-catenin accumulation, a hallmark of activated canonical Wnt signaling pathway. We used HPV16-positive oropharyngeal cancer cell lines 147T and 090, HPV-negative cell line 040T, and cervical cell lines SiHa (bearing integrated HPV16) and HeLa (bearing integrated HPV18) to measure the cytoplasmic and nuclear beta-catenin levels and the beta-catenin/Tcf transcriptional activity before and after E6/E7 gene silencing. Repression of HPV E6 and E7 genes induced a substantial reduction in nuclear beta-catenin levels. Luciferase assay showed that transcriptional activation of Tcf promoter by beta-catenin was lower after silencing. The protein levels of beta-catenin are tightly regulated by the ubiquitin/proteasome system. We therefore performed expression analysis of regulators of beta-catenin degradation and nuclear transport and showed that seven in absentia homologue (Siah-1) mRNA and protein levels were substantially upregulated after E6/E7 repression. Siah-1 protein promotes the degradation of beta-catenin through the ubiquitin/proteasome system. To determine whether Siah-1 is important for the proteasomal degradation of beta-catenin in HPV16-positive oropharyngeal cancer cells, we introduced a Siah-1 expression vector into 147T and 090 cells and found substantial reduction of endogenous beta-catenin in these cells. Thus, E6 and E7 are involved in beta-catenin nuclear accumulation and activation of Wnt signaling in HPV-induced cancers. In addition, we show the significance of the endogenous Siah-1-dependent ubiquitin/proteasome pathway for beta-catenin degradation and its regulation by E6/E7 viral oncoproteins in HPV16-positive oropharyngeal cancer cells.

Citing Articles

Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms.

Saha D, Dutta P, Rebello K, Shankar A, Chakraborty A Mol Cell Biochem. 2025; .

PMID: 40045143 DOI: 10.1007/s11010-025-05236-9.


Distinct immune responses to HIV and CMV in Hofbauer cells across gestation highlight evolving placental immune dynamics.

Schuch V, Hossack D, Hailstorks T, Chakraborty R, Johnson E bioRxiv. 2024; .

PMID: 39605623 PMC: 11601510. DOI: 10.1101/2024.11.21.624730.


Unveiling HPV's hidden link: Cardiovascular diseases and the viral intrigue.

Dutta P, Saha D, Earle M, Prasad C, Singh M, Darswal M Indian Heart J. 2024; 76(1):1-5.

PMID: 38387552 PMC: 10943540. DOI: 10.1016/j.ihj.2024.02.001.


HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.

Peng Q, Wang L, Zuo L, Gao S, Jiang X, Han Y Cancer Gene Ther. 2023; 31(1):9-17.

PMID: 38102462 DOI: 10.1038/s41417-023-00682-3.


The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer.

Aghbash P, Hemmat N, Baradaran B, Mokhtarzadeh A, Poortahmasebi V, Oskuee M Oncol Res. 2023; 30(3):99-116.

PMID: 37305016 PMC: 10208084. DOI: 10.32604/or.2022.026776.